Oncolytics biotech incorporated ONCY.US Value Analysis

US StockHealth Care

ONCY Value Score

3

24

15

Limited Growth
  • AI analysis rates ONCY  with a lower value score of 2.
  • It is mainly due to  unstable operating cash flow, along with potential value may be lower.
  • Over the past 3 months, ONCY has maintained a consecutive value rating of 2.0, close to the rating of 2.3 over the past 3 years, indicating low growth opportunities for enterprise value.
  • Compared to all stocks in the Health Care sector, ONCY has a medium value rating.

ONCY Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

No related data records

ONCY Financial Forecast

Unit : USD

Update to 2024/11/12 (Quarterly Update)

ONCY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.1
16.7%
1%
0
---
2024Q1
-0.09
10%
16.7%
0
---
2023Q4
-0.05
66.7%
66.2%
0
---
2023Q3
-0.14
-75%
-34.6%
0
---
2023Q2
-0.12
-33.3%
-6.2%
0
---

Update to 2024/11/12 (Quarterly Update)

ONCY Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

ONCY Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of ONCY from 2007/01 till Now

-
Cumulative Return
-
Annual Return
-
Volatility
-
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to November, 2024. (Total Trades: 0)

ONCYSectorUS Overall Market
Wining Rate-46%56%
Avg Return-65.1%80.4%
Avg Profit-192.6%170.7%
Avg Loss--44.5%-34.9%
Avg Risk-Reward Ratio-432.8%488.9%

Update to 2024/11/13 (Daily Update)

Top 10 High Relevance to ONCY Value Score